Choose Your language:
- Social bookmarks:
- Testimonials
-
I recieved the order just fine. They work Great.
- Thanks, Larry
Read more »
Our billing is certified by:
- News
-
- FDA approved Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
- Considering the information of three randomized, multicenter, double, blind clinical studies and a retrospective analysis of the medical documentation, FDA approved on October 7, 2011 Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years
- The forming, development and monitoring of the pharmaceutical market in USA in September 2011
- In spite of low rates and stagnation of industrial development, the pharmaceutical market shows a dynamical growth
- Sildenafil citrate and pulmonary arterial hypertension
- Pulmonary arterial hypertension Definition “pulmonary arterial hypertension” is related to a group of diseases characterized by: - Progressive increase in pulmonary vascular resistance; - Reduction in pulmonary bloodflow; - High pulmonary artery pressure; - Contractility of the heart right ventricle; - Right ventricular failure
- Fruit and vegetables do not reduce overall cancer risk, review concludes
- Eating lots of fruit and vegetables will do little to reduce your risk of developing cancer, according to a review of a decade of research involving more than a million people
- Common painkillers could be linked to male reproductive disorder
- The use of mild painkillers, such as paracetamol, in pregnancy – previously considered harmless to the baby in the womb – could be a major factor in the rise of male reproductive disorders, according to a study
-
- Something better than orlistat in preventing obesity or weight gain - Food Consumer
- Something better than orlistat in preventing obesity or weight gainFood ConsumerBy David Liu PHD Thursday April 26, 2012 (foodconsumer
- Weight-loss drug Lorcaserin: Definite maybe in 2nd run at FDA's OK - Los Angeles Times
- AFPWeight-loss drug Lorcaserin: Definite maybe in 2nd run at FDA's OKLos Angeles TimesIf the agency follows the advice of the panel of independent experts--which is common but not routine-- Lorcaserin would become the first new prescription weight-loss drug to go on the US market since Orlistat (now marketed over-the-counter as Alli)
- US panel gives nod to new obesity drug - Hindustan Times
- Hindustan TimesUS panel gives nod to new obesity drugHindustan TimesOne drug, known as Xenical (Orlistat) by Roche and over the counter as Alli by GlaxoSmithKline, works by preventing the body from absorbing fat, though its tendency to cause gastrointestinal side effects such as oily, loose stools have curbed its
- FDA Panel Recommends Lorcaserin for Obesity - Medscape
- InPharmFDA Panel Recommends Lorcaserin for ObesityMedscapeIf granted full approval by the FDA later this year, lorcaserin would become the second prescription medication approved for treating obesity, joining orlistat (Xenical, F
- An Endless Quest for Weight-Loss Pills - New York Times (blog)
- New York Times (blog)An Endless Quest for Weight-Loss PillsNew York Times (blog)The lone prescription drug currently available in America for weight loss, orlistat, offers only minor weight loss with the trade-off of major stomach problems in the form of oily, greasy stools
